SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Gut microbiome alterations may play a paramount role in determining the clinical outcome of clinical COVID-19 with underlying comorbid conditions like T2D, cardiovascular disorders, obesity, etc. Research is warranted to manipulate the profile of gut microbiota in COVID-19 by employing combinatorial...
Main Authors: | Indranil Chattopadhyay, Esaki M. Shankar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.590874/full |
Similar Items
-
ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology
by: Yuexin Guo, et al.
Published: (2021-09-01) -
Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients
by: Phillip A. Engen, et al.
Published: (2021-06-01) -
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01) -
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
by: Mohammad Oves, et al.
Published: (2020-11-01) -
Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01)